Dr David Cutter
Clinical Research Fellow (CTSU) and Consultant Clinical Oncologist (Oxford Cancer Centre)
David Cutter studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre. In 2008 he joined CTSU to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013 he was appointed as a Consultant Clinical Oncologist and continues to work within CTSU upon a programme of work investigating the benefits and risks of cancer treatments.
Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
Ntentas G. et al, (2019), Pract Radiat Oncol, 9, 179 - 187
Cardiac structure doses in women irradiated for breast cancer in the past and their use in epidemiological studies.
Duane FK. et al, (2019), Pract Radiat Oncol
Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era.
Sharpley FA. et al, (2019), PLoS One, 14
Modeling Radiation Therapy-Related Risk of Heart Failure in Survivors of Pediatric Malignancy: Early Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Group
Bates JE. et al, (2018), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102, S53 - S53
Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.
Taylor C. et al, (2018), J Clin Oncol, 36, 2288 - 2296